Biomarkers for the progression of cholangiocarcinoma

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1051627

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Cholangiocarcinoma (CCA) is a form of liver cancer with a devastatingly poor prognosis. In East Asia long term infection with a parasitic worm leads to CCA. Because it is feasible to monitor the development of CCA from the time of infection with the parasite, we propose a biomarker discovery program using CCA samples from liver fluke infected persons in Thailand. This will eventuate in tools for the early diagnosis and early treatment of CCA for those at risk of developing this cancer globally.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $507,347.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Oncology and Carcinogenesis not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

RNA | biomarkers | cholangiocarcinoma | fibrosis | proteomics

Related Links